Login to Your Account

CHMP backs 49 new drug approvals in 2017

By Cormac Sheridan
Staff Writer

Friday, December 15, 2017

DUBLIN – The EMA's Committee for Human Medicinal Products (CHMP) closed out 2017 with recommendations for three new drug approvals and for one new biosimilar, along with positive recommendations for five products approved under the generic, hybrid or informed consent pathways, plus two line extensions.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription